Crosslinked-hyaluronic acid in emulsion
Abstract
The present invention relates to methods of producing crosslinked hyaluronic acid microbeads, as well as the produced microbeads, said method comprising the steps of: (a) mixing an aqueous alkaline solution comprising hyaluronic acid, or a salt thereof, with a solution comprising a crosslinking agent; (b) forming microdroplets having a desired size from the mixed solution of step (a) in an organic or oil phase to form a water in organic or water in oil (W/O) emulsion; (c) continuously stirring the W/O emulsion, whereby the reaction of hyaluronic acid with divinylsulfone takes place to provide crosslinked hyaluronic acid microbeads; and (d) purifying the crosslinked hyaluronic acid microbeads.
Claims
exact text as granted — not AI-modified1 - 42 . (canceled)
43 . A method of producing crosslinked hyaluronic acid microbeads, said method comprising the steps of:
(a) mixing an aqueous alkaline solution comprising hyaluronic acid or a salt thereof, with a solution comprising a crosslinking agent; (b) forming microdroplets having a desired size from the mixed solution of step (a) in an organic or oil phase to form a water in organic or water in oil (W/O) emulsion; (c) continuously stirring the W/O emulsion, whereby the reaction of hyaluronic acid with divinylsulfone takes place to provide crosslinked hyaluronic acid microbeads; and (d) purifying the crosslinked hyaluronic acid microbeads.
44 . The method of claim 43 , wherein the hyaluronic acid or salt thereof is recombinantly produced in a Bacillus host cell.
45 . The method of claim 43 , wherein the hyaluronic acid or salt thereof has a number average molecular weight of between 100 and 3,000 kDa.
46 . The method of claim 43 , wherein the alkaline solution comprises dissolved hyaluronic acid or a salt thereof, in a concentration of between 0.1%-40% (w/v).
47 . The method of claim 43 , wherein the alkaline solution comprises dissolved sodium hydroxide in a concentration of between 0.001 -2.0 M.
48 . The method of claim 43 , wherein the crosslinking agent is divinylsulfone (DVS).
49 . The method of claim 48 , wherein DVS is comprised in the mixed solution of step (a) in a weight ratio of between 1:1 and 100:1 of HA/DVS (dry weight).
50 . The method of claim 43 , wherein the reaction of hyaluronic acid with divinylsulfone takes place at a temperature in the range of 5-100° C.
51 . The method of claim 43 , wherein the stirring in step (c) is continued for a period of between 1-180 minutes.
52 . The method of claim 43 , wherein the microdroplets of step (b) have an average diameter in the range of about 1 nanometer to 1 millimeter.
53 . The method of claim 43 , wherein the purifying step comprises dialyzing the crosslinked microbeads against de-ionized water using a dialysis membrane that allows free diffusion of molecules having a size less than 13,000 daltons.
54 . The method of claim 43 , wherein the purifying step comprises neutralizing the pH of the crosslinked microbeads with a buffer or an acid.
55 . The method of claim 54 , wherein the buffer comprises a buffer with a pH in the range of 2.0-8.0.
56 . The method of claim 54 , wherein the buffer comprises a buffer with a pH, which results in that the crosslinked microbeads have a pH between 5.0 and 7.5 after the purifying step.
57 . The method of claim 54 , wherein the buffer comprises a phosphate buffer and/or a saline buffer.
58 . The method of claim 43 , wherein the crosslinked microbeads are washed at least once with water, and/or a phosphate and/or saline buffer with a pH in the range of 2.0-8.0.
59 . The method of claim 43 , wherein a preservative is added as a component to the crosslinked microbeads either before or after the crosslinking reaction.Join the waitlist — get patent alerts
Track US2010311963A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.